This inventor holds 2 USPTO granted patents. Top assignee: Utrecht University. Active years: 2008-2010.
Company Filing History:
Years Active: 2008-2010
Title: Innovations of Erik De Vries
Introduction
Erik De Vries is a notable inventor based in Rhenen, Netherlands. He has made significant contributions to the field of biotechnology, particularly in vaccine development. With a total of two patents to his name, his work focuses on innovative solutions for health-related challenges.
Latest Patents
One of Erik De Vries's latest patents is centered around a Piroplasmid vaccine. This invention relates to a Piroplasmid protein or an immunogenic fragment of the protein, along with a nucleic acid encoding the Piroplasmid protein or immunogenic fragment. The patent also covers cDNA fragments, recombinant DNA molecules, and live recombinant carriers that incorporate the nucleic acid. Additionally, it includes host cells that comprise these cDNA fragments and recombinant DNA molecules. The invention further extends to vaccines that contain a Piroplasmid protein or its immunogenic fragments, methods for preparing such vaccines, and their use for vaccine purposes and diagnostic tests.
Career Highlights
Erik De Vries is associated with Universiteit Utrecht Holding B.V., where he continues to advance his research and innovations. His work has the potential to impact the field of immunology and vaccine development significantly.
Collaborations
Erik collaborates with talented individuals such as Fasila Razzia Gaffar and Ana Patricia Yatsuda, contributing to a dynamic research environment.
Conclusion
Erik De Vries exemplifies the spirit of innovation in biotechnology through his work on Piroplasmid vaccines. His contributions are paving the way for advancements in vaccine technology and public health.